Cryo-Cell International, Inc.
Save
72.72M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Care Facilities
Industry
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells.
Similar securities
Based on sector and market capitalization
Report issue